BioMed Pharma Inc. started during the latter part of 2009 and concentrated on having its generic medicines registered and approved by the then Bureau of Food and Drugs (now called Food and Drugs Administration). Sales operation started in January 2012 when eight (8) Certificate of Product Registration were released from the FDA.
BioMed Pharma Inc. is centrally located at the heart of bustling Manila, at Suite 711, Marbella 2 Bldg, 2027, Roxas Boulevard, Malate, Manila 2071, Philippines. BioMed’s official mandate is the importation, distribution and wholesale of quality and affordable generic medicines.
BioMed Pharma Inc. is strongly supported by Delta Pharma Limited, the manufacturer of its line up of quality generics medicines. The Chief Executive Officer of BioMed Pharma Inc. is Dr. Md. Zakir Hossain, concurrently the Managing Director of Delta Pharma Limited.
The manufacturing of the branded generic medicines of Biomed Pharma Inc. occurs at Kishoreganj, Bangladesh using state-of-the-art technology & equipments, ably manned by qualified quality assurance and control personnel, and using raw materials from highly reputable national and international suppliers thereby ensuring compliance to the guidelines of WHO Good Manufacturing Practices and of the Drug Administration Authority.
To date, BioMed Pharma Inc. have twenty eight (28) branded generic medicines duly approved by FDA Philippines and with Certificates of Product Registration (CPR).
OUR COMMITMENT
BioMed Pharma Inc. stands by its two-pronged commitment of importation of “high quality branded generic medicines at affordable prices”. To embody this commitment to quality, BioMed have adopted the slogan “Mabisang Gamot, sa Presyong Abot na Abot”.
BioMed Pharma Inc. continues to look for dynamic people, organizations and companies who will join its growing network of distributors and wholesalers. Presently, BioMed medicines are being distributed in five regions. It continues to look for possible distributors / wholesalers in other regions not covered by its present network of distributors and wholesalers.
To further increase awareness of its quality line of branded generic medicines, BioMed Pharma also joins selected high impact events around the country.
BIOMED’s niche is the branded generic segment which is known for its comparable quality with originator brands but with affordable generic prices. The generic drug market is still an under-served market segment of the Philippine pharma market; hence, it presents concrete and realistic opportunities for Distributors and Wholesalers to penetrate and capture significant business opportunities in areas where they operate. Quality and profitability are assured with Biomed products.
The increase in the number of distributors and wholesalers will also lead to the Biomed brand becoming known in the pharmaceutical industry and lead to getting a market share of the generic medicine market for Biomed, and to grow / expand its market to include other products, like vials and injectables, within the near future.
GROWTH WITH DISTRIBUTORS
We are committed to grow with distributors based on product – area. We continuously communicate with distributors by having regular updates and meetings, to better monitor the movement of Biomed products vis-à-vis competitor products.
The regular meetings and updates with distributors are also avenues for exchange of ideas on strategies, possible new products based on demand from the area and other developments.